Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · IEX Real-Time Price · USD
15.74
-0.08 (-0.51%)
At close: Mar 27, 2024, 4:00 PM
15.72
-0.02 (-0.13%)
Pre-market: Mar 28, 2024, 7:14 AM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Hims & Hers Health stock have an average target of 12.8, with a low estimate of 10 and a high estimate of 17. The average target predicts a decrease of -18.68% from the current stock price of 15.74.
Analyst Consensus: Buy
* Price targets were last updated on Feb 27, 2024.
Analyst Ratings
The average analyst rating for HIMS stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 3 | 3 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 5 | 5 | 5 | 4 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 12 | 12 | 12 | 11 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +8.01% | Feb 27, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $12 → $16 | Strong Buy | Maintains | $12 → $16 | +1.65% | Feb 27, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $9 → $11 | Hold | Maintains | $9 → $11 | -30.11% | Feb 27, 2024 |
Truist Securities | Truist Securities | Hold Maintains $10 → $13 | Hold | Maintains | $10 → $13 | -17.41% | Feb 27, 2024 |
Leerink Partners | Leerink Partners | Hold Initiates $10 | Hold | Initiates | $10 | -36.47% | Feb 26, 2024 |
Financial Forecast
Revenue This Year
1.20B
from 872.00M
Increased by 37.27%
Revenue Next Year
1.48B
from 1.20B
Increased by 23.48%
EPS This Year
0.05
from -0.11
EPS Next Year
0.21
from 0.05
Increased by 327.07%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.3B | 1.6B | 2.1B | 1.9B | 2.1B |
Avg | 1.2B | 1.5B | 1.8B | 1.8B | 2.0B |
Low | 1.1B | 1.2B | 1.6B | 1.7B | 1.9B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 45.1% | 36.9% | 40.5% | 0.9% | 15.6% |
Avg | 37.3% | 23.5% | 24.4% | -2.0% | 12.3% |
Low | 20.6% | 1.8% | 6.9% | -5.8% | 7.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 0.15 | 0.35 | 0.51 | 0.66 | 0.81 |
Avg | 0.05 | 0.21 | 0.36 | 0.64 | 0.79 |
Low | -0.11 | 0.02 | 0.16 | 0.62 | 0.75 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 615.2% | 148.7% | 85.3% | 25.8% |
Avg | - | 327.1% | 72.5% | 80.0% | 22.2% |
Low | - | -59.5% | -24.2% | 72.9% | 17.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.